Speed of response to bilateral ECT: An examination of possible predictors in two controlled trials

Journal of ECT

Volumn 15, Issue 3, 1999, Pages 202-206

  Shapira, B ^a   Lerer, B ^b  

^a HERZOG HOSPITAL   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Electroconvulsive therapy; Response speed

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033190892     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. American Psychiatric Association. The practice of ECT: Recommendations for Practice, Training and Privileging: Task Force Report on ECT, Washington. DC: American Psychiatric Press, 1990.
2. Ancy J, Gangadhar BN, Janakiramaiah N. Normal P300 amplitude predicts rapid response to ECT in melancholia. J Affect Disord 1996;41:211-5.
3. Andrade C, Gangadhar BN, Swaminath G, Channabasavanna SM. Predicting the outcome of endogenous depression following electroconvulsive therapy. Convuls Ther 1988;4:169-74.
4. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: NIMH, 1976:217-22.
5. Kellner CH, Russell R, Monroe JR, Pritchett J, Jarrell MP, Bernstein HJ, Burns CM, Weekly ECT in geriatric depression. Convulsive Ther 1992;8:245-52.
6. Kindler S, Shapira B, Hadjez J, Abramowitz M, Brom D, Lerer B. Factors influencing response to bilateral ECT in major depression. Convulsive Ther 1991;7:245-54.
7. Kukopulos A, Reginaldi D, Tondo L, Bernabei A, Calieri B. Spontaneous length of depression and response to ECT. Psychol Med 1977;7:626-9.
8. Lerer B, Shapira B, Calev A, Tubi N, Drexler H, Kindler S, Linsky D, Schwartz JE. Antidepressant and cognitive adverse effects of twice versus three times weekly ECT. Am J Psychiatry 1995;152:564-70.
9. Lerer B, Shapira B. How resistant is resistant depression? Focus on electroconvulsive therapy. Ear Neuropsychopharmacol 1994;4:211-2.
10. Price TRP, McAllister TW, Tucker GJ, Culver C. The dose response ratio to electroconvulsive therapy. Arch Gen Psychiatry 1978;35:1131-6.
11. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990;31:287-96.
12. Rich CL, Spiker DG, Jewell SW, Neil JF, Black NA. The efficiency of ECT: 1. Response in depressive episodes. Psychiatry Res 1984;11:167-76.
13. Sackeim HA, Decina P. Prohovnik I, Malitz S, Seizure threshold in ECT: effects of sex, age, electrode placement and number of treatments. Arch Gen Psychiatry 1987;44:355-60.
14. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990;10:96-104.
15. Segman RH, Shapira B, Gorfine M, Lerer B. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology 1995;119: 440-8.
16. Shapira B, Gorfine M, Lerer B. A prospective study of lithium continuation therapy in depressed patients who have responded to ECT. Convulsive Ther 1995;11:80-5.
17. Shapira B, Lidsky D, Gorfine M, Lerer B. Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold. J Clin Psychiatry 1996;57:32-8.
18. Shapira B, Tubi N, Drexler H, Lidsky D, Calev A, Lerer B. Cost and benefit in the choice of ECT schedule: a new controlled trial of twice versus three times weekly ECT. Br J Psychiatry 1998;172:44-8.
19. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria for a selected group of functional disorders. New York: New York Psychiatric Institute, 1989.